Exhibit 99.1 Surgery Partners had cash and cash equivalents of $185.2 million and $607.3 million of borrowing capacity under its revolving credit facility at March 31, 2024. Cash flows from operating activities was $40.7 million for the first quarter of 2024, compared to $74.5 million in the prior year quarter. The year-over-year change is due to the timing of receivable collections, the majority of which has been received or is expected to be received in the second/early third quarter of 2024. The Company ...

Surgery Partners, Inc. (NASDAQ:SGRY) Q4 2023 Earnings Conference Call February 26, 2024 8:30 AM ET Company Participants Dave Doherty - Chief Financial Officer Wayne DeVeydt - Executive Chairman Eric Evans - Chief Executive Officer Conference Call Participants Brian Tanquilut - Jefferies Kevin Fischbeck - Bank of America Jason Cassorla - Citi Lisa Gill - JPMorgan Bill Sutherland - The Benchmark Company Sarah James - Cantor Fitzgerald Gary Taylor - TD Cowen Ben Hendrix - RBC Capital Markets Operator Greetings ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________________________________________ Form 10-K ☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2023 OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission file number: 001-37576 Surgery Partners, Inc. (Exact name of registrant as specified in its charter) Delaware 47-3620923 (State o ...

Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2023 RESULTS; SETS 2024 GUIDANCE BRENTWOOD, Tenn., February 26, 2024 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the fourth quarter and full year ended December 31, 2023. Wayne DeVeydt, Chairman of the Board of Surgery Partners, noted, "We are pleased to report another year of mid-teens growth with ...

Surgery Partners, Inc. (NASDAQ:SGRY) Q3 2023 Earnings Call Transcript November 7, 2023 8:30 AM ET Company Participants Dave Doherty - CFO Wayne DeVeydt - Executive Chairman Eric Evans - CEO Conference Call Participants Kevin Fischbeck - Bank of America Jason Cassorla - Citi Whit Mayo - Leerink Partners Brian Tanquilut - Jefferies Sarah James - Cantor Fitzgerald Ann Hynes - Mizuho Securities Bill Sutherland - Benchmark Company Ben Hendrix - RBC Capital Markets Operator Good morning, ladies and gentlemen, and ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________ Form 10-Q _____________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 Delaware 47-3620923 (I.R.S. Employer Identification No.) (State or other jurisdiction of incorporation or organization) Brentwood, Tennessee 37027 (615) 234-5900 (Registrant's telephone number, including ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________ Form 10-Q _____________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37576 _____________________________________ Surgery Partners, Inc. (Exact name of regi ...

Surgery Partners, Inc. (NASDAQ:SGRY) Q2 2023 Earnings Conference Call August 1, 2023 8:30 AM ET Company Participants Dave Doherty - CFO Wayne DeVeydt - Executive Chairman Eric Evans - CEO Conference Call Participants Jason Cassorla - Citigroup Kevin Fischbeck - Bank of America Gary Taylor - Cowen Brian Tanquilut - Jefferies Whit Mayo - Leerink Partners Lisa Gill - JPMorgan Operator Good morning, and welcome to the Surgery Partners Second Quarter 2023 Earnings Conference Call. At this time, all participants ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________ Form 10-Q _____________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37576 _____________________________________ Surgery Partners, Inc. (Exact name of reg ...

Surgery Partners, Inc. (NASDAQ:SGRY) Q1 2023 Earnings Conference Call May 1, 2023 5:00 PM ET Company Participants Dave Doherty - Executive Vice President and Chief Financial Officer Wayne DeVeydt - Executive Chairman Eric Evans - Chief Executive Officer Conference Call Participants Jason Cassorla - Citi Nabil Gutierrez - Bank of America Brian Tanquilut - Jefferies Lisa Gill - JPMorgan Whit Mayo - SVB Securities Bill Sutherland - The Benchmark Company Stephen Valiquette - Barclays Operator Greetings, and wel ...